A chitinase mutant PbCHI2-D645W and its applications
By site-directed mutation of the D645 site of chitinase PbCHI2 to Trp, the substrate binding channel was optimized, improving the catalytic activity and product generation efficiency of chitinase. This solved the problem of insufficient chitinase activity in the existing technology and is suitable for industrial production and resource utilization.
Patent Information
- Application Number
- CN202611624359.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-10-20
- Publication Date
- 2026-11-17
AI Technical Summary
Existing chitinases have low catalytic activity and insufficient thermal stability, making it difficult to meet the needs of industrial applications. Furthermore, site-directed mutagenesis is unpredictable and leads to a decrease in activity.
By site-directed mutagenesis of the 645th amino acid residue of the chitinase PbCHI2 derived from *Luminobacterium luminiferum*, aspartic acid (Asp) was replaced with tryptophan (Trp), a chitinase mutant PbCHI2-D645W was formed. This optimized substrate binding channels and hydrophobic interactions, thereby improving catalytic efficiency.
The mutant PbCHI2-D645W showed a 23.6% increase in specific enzyme activity and an 11.26% and 14.37% increase in the yields of products GlcNAc and (GlcNAc)2, respectively. It retained its low-temperature adaptability and alkali preference, making it suitable for industrial production.
Smart Images

Figure CN123107971A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the fields of enzyme engineering and genetic engineering technology, specifically relating to a chitinase mutant PbCHI2-D645W and its applications. Background Technology
[0002] Chitin is the second most abundant natural polysaccharide after cellulose. It is composed of N-acetylglucosamine (GlcNAc) linked by β-1,4-glycosidic bonds and is widely found in shrimp and crab shells, insect exoskeletons, and fungal cell walls. Globally, approximately 6-8 million tons of shrimp and crab shell waste are generated annually, most of which is directly discarded or landfilled, causing serious resource waste and environmental pollution. The enzymatic degradation products of chitin—N-acetylglucosamine and chitooligosaccharides—have wide applications in food, medicine, agriculture, and cosmetics: GlcNAc can be used as an additive in joint health foods and a precursor to anti-inflammatory drugs; chitooligosaccharides possess antibacterial, immunomodulatory, and plant growth-promoting biological activities.
[0003] Chitinase (EC 3.2.1.14) specifically hydrolyzes the β-1,4-glycosidic bonds in chitin, making it a key enzyme for the biotransformation and utilization of chitin. Based on amino acid sequence homology, chitinase belongs to the glycosidic hydrolase family 18 (GH18) and 19 (GH19). GH18 family chitinases are widely distributed in bacteria, fungi, insects, and higher organisms, and their catalytic mechanism is a substrate-assisted retention dual displacement mechanism. However, currently reported chitinases generally suffer from low catalytic activity, insufficient thermal stability, or low degradation efficiency of crystalline chitin, limiting their industrial applications. Marine-derived chitinases have attracted widespread attention due to their unique low-temperature adaptability and alkali preference, but the catalytic efficiency of wild-type enzymes still falls short of the demands of industrial production.
[0004] Protein engineering strategies (especially site-directed mutagenesis and rational design) provide effective means to improve enzyme catalytic performance. By locating key amino acid residues near the active site or substrate binding channel through structural analysis and performing targeted mutations, the catalytic efficiency, substrate specificity, and stability of enzymes can be significantly improved. However, mutations at the enzyme active site usually lead to a decrease in activity, and obtaining mutants with improved activity is unpredictable, requiring extensive screening.
[0005] Therefore, developing highly active chitinase mutants is of great significance for promoting the resource utilization of chitin waste and the green industrial production of GlcNAc / chitin oligosaccharides. Summary of the Invention
[0006] To overcome the shortcomings of the prior art, this invention provides a chitinase mutant PbCHI2-D645W and its application. Compared with wild-type PbCHI2, PbCHI2-D645W has a higher specific enzyme activity than wild-type PbCHI2 when using 4-MU-GlcNAc3 as a substrate, increasing from 19.15 U / mg to 23.68 U / mg, representing a 23.6% increase in activity. This significantly improves catalytic efficiency and helps reduce enzyme usage and costs in industrial applications.
[0007] The above-mentioned objective of this invention is achieved through the following technical solution: In a first aspect, the present invention provides a chitinase mutant PbCHI2-D645W.
[0008] The chitinase mutant PbCHI2-D645W is derived from luminescent bacteria ( Photobacterium sp. LG-29 It was obtained by site-directed mutation of amino acid 645—aspartic acid (Asp, D)—to tryptophan (Trp, W) in wild-type chitinase PbCHI2 (whose amino acid sequence is shown in SEQ ID NO:1, consisting of 878 amino acid residues).
[0009] The nucleotide sequence of the gene encoding the wild-type chitinase PbCHI2 is shown in SEQ ID NO:2, with a full length of 2634 bp and GenBank accession number OR995198.1.
[0010] The wild-type chitinase PbCHI2 belongs to the glycoside hydrolase 18 family (GH18), with a molecular weight of 99.1 kDa and a theoretical isoelectric point of 4.3. Its domain composition includes: an N-terminal Glyco_18 catalytic domain, a C-terminal ChtBD3 chitin-binding domain, three PKD domains, and a signal peptide composed of amino acids 1-24 at the N-terminus. The amino acid sequence of the mutant PbCHI2-D645W is shown in SEQ ID NO:3.
[0011] Compared with wild-type PbCHI2, the mutant PbCHI2-D645W showed an increase in specific enzyme activity of 23.68 U / mg with 4-methylumbelliferone-β-DN,N',N"-triacetylchitoside (4-MU-GlcNAc3) as substrate, from 19.15 U / mg, representing an increase of 23.6%.
[0012] Secondly, the present invention provides a gene encoding the chitinase mutant PbCHI2-D645W.
[0013] The gene was obtained by mutating the codon (GAC / GAT) encoding aspartic acid at position 645 in the wild-type PbCHI2 coding gene (SEQ ID NO:2) to the codon (TGG) encoding tryptophan. The nucleotide sequence of the gene is shown in SEQ ID NO:4.
[0014] Thirdly, the present invention provides a recombinant vector.
[0015] The recombinant vector contains the gene encoding the chitinase mutant PbCHI2-D645W.
[0016] The recombinant vector is preferably pET-28a(+), and the gene is inserted into the multiple cloning site of the vector through the restriction enzyme sites Nde I and Xho I, so that the target protein is expressed as an N-terminal His-tag fusion protein.
[0017] Fourthly, the present invention provides a recombinant strain.
[0018] The recombinant strain contains the recombinant vector, or has integrated the gene encoding the chitinase mutant PbCHI2-D645W into its genome.
[0019] Preferably, the host of the recombinant strain is Escherichia coli, more preferably Escherichia coli BL21(DE3).
[0020] Fifthly, the present invention provides the application of the chitinase mutant PbCHI2-D645W in the degradation of chitin or chitin-containing biomass.
[0021] The chitin-containing biomass is colloidal chitin.
[0022] The degradation products are N-acetylglucosamine (GlcNAc) and / or chitosan oligosaccharides, preferably GlcNAc and (GlcNAc)2. Compared with wild-type PbCHI2, the mutant PbCHI2-D645W showed an increase of 11.26% and 14.37% in the yield of GlcNAc and (GlcNAc)2 produced from the degradation of colloidal chitin, respectively.
[0023] In a sixth aspect, the present invention provides a method for degrading chitin or chitin-containing biomass.
[0024] The method uses the chitinase mutant PbCHI2-D645W or the recombinant strain to contact a chitin-containing substrate and carry out an enzymatic hydrolysis reaction under suitable conditions.
[0025] Preferably, the enzymatic hydrolysis reaction conditions are: pH 7.0-8.5, temperature 30-40℃, more preferably pH 8.0, temperature 35℃, and reaction time 2-24 hours. The substrate is 2% (w / v) colloidal chitin, and the enzyme concentration is 50 μg / mL.
[0026] The advantages of this invention compared to the prior art are: (1) The chitinase mutant PbCHI2-D645W provided by the present invention, compared with wild type PbCHI2, has a specific enzyme activity of 23.68 U / mg when using 4-MU-GlcNAc3 as substrate, which is increased from 19.15 U / mg. The activity is increased by 23.6%, and the catalytic efficiency is significantly improved, which is beneficial to reducing the amount of enzyme used and the cost in industrial applications.
[0027] (2) This mutant targets the key amino acid residue D645 near the substrate-binding channel, which is located in the substrate-binding region of the catalytic domain. The mutation to tryptophan (Trp) introduces a larger hydrophobic side chain, enhancing substrate binding and product release efficiency by optimizing the spatial conformation and hydrophobic interactions of the substrate channel. Meanwhile, structural analysis using the DbDhomology model suggests that the D645W mutation may improve catalytic efficiency by affecting the local conformation of the substrate-binding pocket.
[0028] (3) The present invention also provides mutants with decreased activity such as D645Y, P639F, D645V, and Y643M as comparisons, clarifying the key role of the D645 site mutation to Trp, excluding other mutation forms, and making the scope of protection clearer.
[0029] (4) The recombinant vector and recombinant strain provided by the present invention can achieve efficient soluble expression of mutants in Escherichia coli BL21(DE3), and can be induced to express under the conditions of 15°C and 0.1 mM IPTG, which is convenient for industrial scale-up production.
[0030] (5) The mutant can effectively degrade colloidal chitin to produce GlcNAc and (GlcNAc)2. The yields of GlcNAc and (GlcNAc)2 in the degradation products are increased by 11.26% and 14.37%, respectively, providing a new technical solution for the resource utilization of chitin waste.
[0031] (6) This mutant retained the low-temperature adaptability and alkali preference characteristics of wild-type PbCHI2, exhibiting optimal activity at 35°C and pH 8.0. 2+ Ca 2+ Mg 2+ It has an activating effect on its activity and has good industrial application characteristics. Attached Figure Description
[0032] The present invention will be further described below with reference to the accompanying drawings and specific embodiments. Figure 1 This is an SDS-PAGE electrophoresis image of the purified recombinant chitinase PbCHI2 of this invention; Lane M: medium molecular weight protein standard; Lane 1: Tris-HCl eluted protein; Lane 2: purified PbCHI2; Figure 2 The optimal temperature and temperature stability of chitinase PbCHI2; (a) optimal temperature with 2% colloidal chitin as substrate; (b) temperature stability with 2% colloidal chitin as substrate; (c) optimal temperature with 4-MU-GlcNAc3 as substrate; (d) temperature stability with 4-MU-GlcNAc3 as substrate; Figure 3 The optimal pH and pH stability analysis of chitinase PbCHI2; (a) optimal pH analysis; (b) pH stability analysis; Figure 4 The effects of different concentrations of metal ions and chemical reagents on the activity of chitinase PbCHI2 were investigated; (a) the effect of 1 mmol / L metal ions and chemical reagents on PbCHI2 activity; (b) the effect of 5 mmol / L metal ions and chemical reagents on PbCHI2 activity. Figure 5 This is a molecular docking diagram of the active sites of PbCHI2; hydrogen bonds (blue): Val496 (2.8A), Gln497 (3.1A), Glu542 (2.9A), Tyr658 (3.0A), Arg687 (2.7A); salt bridge (yellow dashed line): Glu727 (2.5A); hydrophobic interaction (gray dashed line): Thr78 (4.2A); Figure 6 HPLC analysis of colloidal chitin hydrolysis products; (a) HPLC analysis of PbCHI2-degraded colloidal chitin hydrolysis products, A line is (GlcNAc). 1-6 (a) Standard peak; (b) HPLC analysis of the hydrolysis products of colloidal chitin degraded by the D645W mutant; Figure 7 The enzyme activity and ΔΔG value of PbCHI2 and its mutants are shown. Detailed Implementation
[0033] The present invention is described in detail below through specific embodiments, but this does not limit the scope of protection of the present invention. Unless otherwise specified, the experimental methods used in the present invention are all conventional methods, and the experimental equipment, materials, reagents, etc. used can all be obtained commercially.
[0034] Example 1: Cloning and expression vector construction of PbCHI2 wild-type gene Using Photobacterium sp. LG-29 (accession number OK040506.1) genomic DNA as a template, specific primers were designed to amplify the full-length coding gene of PbCHI2 (SEQ ID NO:2, 2634 bp, GenBank accession number: OR995198.1). The PCR product was double-digested with Nde I and Xho I, and then ligated into the pET-28a(+) vector digested with the same enzymes to obtain the recombinant expression plasmid pET-28a-PbCHI2. The recombinant plasmid was transformed into Escherichia coli BL21(DE3) competent cells, plated on LB agar plates containing 50 μg / mL kanamycin, and incubated overnight at 37°C. Positive clones were picked for sequencing verification.
[0035] Example 2: Site-directed mutagenesis to construct the PbCHI2-D645W mutant, gene sequence of which is SEQ ID NO:4 Using the recombinant plasmid pET-28a-PbCHI2 as a template, site-directed mutagenesis was performed using overlap extension PCR. A mutation primer pair containing the D645W mutation (GAC→TGG) was designed, and PCR amplification yielded the full-length gene fragment containing the mutation site. The mutated gene fragment was digested with Nde I / Xho I and ligated into the pET-28a(+) vector to obtain the recombinant expression plasmid pET-28a-PbCHI2-D645W. This plasmid was transformed into *E. coli* BL21(DE3), and sequencing confirmed the correct mutation.
[0036] The D645Y, P639F, D645V, and Y643M mutants were constructed using the same method as controls.
[0037] Example 3: Induction and purification of recombinant protein BL21(DE3) strains containing each recombinant plasmid were inoculated into LB medium containing 50 μg / mL kanamycin and cultured at 37°C and 200 rpm until OD500. 600 The concentration was approximately 0.6-0.8. IPTG was added to a final concentration of 0.1 mM, and expression was induced at 15°C and 180 rpm for 16-20 hours. The bacterial cells were collected by centrifugation, resuspended in lysis buffer (50 mM Tris-HCl, pH 8.0, 300 mM NaCl, 10 mM imidazole), sonicated, and centrifuged at 4°C and 12000 rpm for 30 min. The supernatant was purified by Ni-NTA affinity chromatography, and the target protein was eluted with elution buffer containing 250 mM imidazole. The purity was detected by SDS-PAGE, and the protein was concentrated by ultrafiltration and stored at -80°C.
[0038] Example 4: Enzyme Activity Assay Chitinase activity was determined using a 4-methylumbelliferone fluorescent substrate method. 4-MU-GlcNAc3 was used as the substrate. The reaction system contained: 50 mM Tris-HCl buffer (pH 8.0), an appropriate amount of enzyme solution, and 5 μM substrate. The reaction was carried out at 35°C for 30 min, and the fluorescence intensity was measured (excitation wavelength 360 nm, emission wavelength 450 nm). One unit of enzyme activity (U) was defined as the amount of enzyme required to release 1 μmol of 4-methylumbelliferone (4-MU) per minute under the above conditions.
[0039] The degradation activity against colloidal chitin was determined using the DNS (3,5-dinitrosalicylic acid) method. Using 1% (w / v) colloidal chitin as a substrate, the reaction was carried out at 35°C and pH 8.0, and the amount of reducing sugar released was determined by the DNS method.
[0040] Example 5: Comparison of enzyme activities between wild type and mutant The enzyme activities of wild-type PbCHI2 and each mutant were measured under the same conditions. The results are shown in Table 1.
[0041] Table 1. Comparison of specific enzyme activities between wild-type PbCHI2 and various mutants (using 4-MU-GlcNAc3 as substrate) The results showed that the specific enzyme activity of the PbCHI2-D645W mutant was 123.6% of that of the wild type, meaning the activity was increased by 23.6%. Meanwhile, the specific enzyme activities of the D645Y, P639F, D645V, and Y643M mutants were all lower than those of the wild type, further demonstrating that the mutation at the D645 site to Trp is the key to improving activity.
[0042] Example 6: Enzymatic Properties Analysis The optimal pH and temperature for the mutant PbCHI2-D645W were determined. Enzyme activity was measured using 4-MU-GlcNAc3 as a substrate under different pH buffers (3.0-10.0) and different temperatures (20-70°C). The results showed that the optimal temperature for the mutant PbCHI2-D645W was 35°C, and the optimal pH was 8.0, consistent with the wild type, retaining the low-temperature adaptability and alkalinity preference characteristics of the wild type.
[0043] Experiments on the effects of metal ions show that Mn 2+ Ca 2+ Mg 2+ It has an activating effect on the activity of the mutant PbCHI2-D645W, while Fe 2+ Zn 2+ Cu2+ Cd 2+ Fe 3+ It has an inhibitory effect, consistent with the wild type.
[0044] Example 7: Degradation of colloidal chitin and analysis of its products Using 2% (w / v) colloidal chitin as a substrate, 50 μg / mL of wild-type PbCHI2 and mutant PbCHI2-D645W enzyme solutions (final concentration appropriately) were added. The enzymatic hydrolysis reaction conditions were: pH 7.0-8.5, temperature 30-40℃, more preferably pH 8.0 and temperature 35℃, for 12-24 hours. The degradation products were analyzed by HPLC. The results showed that the main degradation products of both enzymes were GlcNAc and (GlcNAc)2. Compared with the wild type, the PbCHI2-D645W mutant produced an 11.26% higher yield of GlcNAc and a 14.37% higher yield of (GlcNAc)2.
[0045] Example 8: Degradation experiment of colloidal chitin Colloidal chitin was used as the substrate. A 2% (w / v) chitin suspension was treated with PbCHI2-D645W mutant enzyme solution (50 μg / mL) at pH 7.0-8.5 and temperature 30-40℃, preferably at pH 8.0 and temperature 35℃ for 12-24 hours. The degradation products were analyzed by HPLC or TLC. The results showed that GlcNAc and (GlcNAc)2 were the major products.
[0046] The embodiments described above are merely preferred embodiments of the present invention, and not all feasible embodiments of the present invention. Any obvious modifications made by those skilled in the art without departing from the principles and spirit of the present invention should be considered to be included within the scope of protection of the claims of the present invention.
Claims
1. A chitinase mutant PbCHI2-D645W, characterized in that, The amino acid sequence of the chitinase mutant PbCHI2-D645W is shown in SEQ ID NO:
3. It was obtained by site-directed mutation of amino acid 645 of PbCHI2—aspartic acid—to tryptophan. The amino acid sequence of PbCHI2 is shown in SEQ ID NO:
1. The nucleotide sequence of the coding gene of PbCHI2 is shown in SEQ ID NO:
2. The full length is 2634 bp, and the GenBank accession number is OR995198.
1.
2. The chitinase mutant PbCHI2-D645W encoding gene of claim 1, wherein, The nucleotide sequence of the encoding gene is shown in SEQ ID NO:
4.
3. A recombinant vector, characterized in that, The recombinant vector contains the encoding gene of the chitinase mutant PbCHI2-D645W as described in claim 2.
4. The recombinant vector of claim 3, wherein, The recombinant vector is pET-28a(+), and the gene is inserted into the multiple cloning site of the vector through the restriction enzyme sites Nde I and Xho I, so that the target protein is expressed as an N-terminal His-tag fusion protein.
5. A recombinant bacterial strain, characterized in that, The recombinant strain contains the recombinant vector of claim 3, or integrates the coding gene of the chitinase mutant PbCHI2-D645W of claim 2 into its genome.
6. The recombinant bacterial strain of claim 5, wherein, The host of the recombinant strain is Escherichia coli.
7. The application of the chitinase mutant PbCHI2-D645W as described in claim 1 in the degradation of chitin or chitin-containing biomass.
8. Use of the chitinase mutant PbCHI2-D645W according to claim 7 for degrading chitin or chitin-containing biomass. characterized in that, The chitin-containing biomass is colloidal chitin, and the degradation products are N-acetylglucosamine and / or chitosan oligosaccharides.
9. A method of degrading chitin or a chitin-containing biomass, characterized by, The chitinase mutant PbCHI2-D645W of claim 1 or the recombinant strain of claim 5 is used to carry out an enzymatic hydrolysis reaction in contact with a chitin-containing substrate.
10. The method of degrading chitin or chitin-containing biomass according to claim 9, wherein, The enzymatic hydrolysis reaction conditions were: pH 7.0-8.5, temperature 30-40℃, reaction time 2-24 hours, substrate 2% (w / v) colloidal chitin, and enzyme concentration 50 μg / mL.
